Prostate Cancer PLND Might Be Avoidable in Some With Negative PSMA PET/CT
In patients with high-risk prostate cancer, negative PSMA PET/CT does not permit PLND avoidance, investigators cautioned.
All articles by Natasha Persaud
Metastatic Prostate Cancer Continues to Rise in US
Reduced prostate cancer screening after USPSTF guidance changes may have contributed to an increase in diagnoses of metastatic disease, according to investigators.
Prostate MRI to Diagnose Prostate Cancer Less Likely in Black Men
Racial disparity in the use of emerging diagnostic technologies may widen gaps in cancer treatment and outcomes, according to investigators.
Prostate Cancer Screening Practices Often Differ From Guidelines
Among US cancer centers, 26% recommend that all men universally receive PSA screening, without advising shared decision-making.
Radical Cystectomy vs Trimodal Tx for cT3 MIBC May Offer Better Survival
Increasing T stage has been associated with reduced long-term survival after trimodal therapy.
Prostate Cancer ADT Plus Radiation Improves Metastasis-Free Survival
Prolonging adjuvant ADT to 18–36 months provides a metastasis-free survival benefit, regardless of radiation dose, in men with intermediate- to high-risk prostate cancer.
Cytoreductive Nephrectomy May Improve Survival in ICI-Treated mRCC
In the era of immune checkpoint inhibitors, cytoreductive nephrectomy retains an important role in mRCC in carefully selected patients, according to investigators.
PD-L1 Expression May Help Predict BCG Response in High-Grade NMIBC
Patients with PD-L1 expression at initial transurethral resection for bladder cancer were more likely to harbor invasive disease, according to investigators.
Cytokines Linked With Survival Outcomes in Nivolumab-Treated mRCC
Validation of the cytokine markers within the entire NIVOREN study is ongoing.
Early Salvage Radiation After RP Improves Outcomes in Relapsed Prostate Cancer
Early-salvage radiation therapy was associated with reduced risks for biochemical recurrence and metastasis, compared with expectant management.
- Loading...
Loading...
Next post in ASCO GU 2022
Loading... 
Loading...